Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis

Conclusion: CD34, CD133 and Nucleostemin might represent useful prognostic markers in patients affected by esophageal cancer.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Elisabetta Trevellin, Giovanni Pirozzolo, Matteo Fassan, Roberto Vettor Tags: Research Paper Source Type: research